Figure B and Figure 2 describe the flow of articles through the screening and review process. 4,293 unique citations were identified. During the title and abstract screening we excluded 3,303 citations; during the full-text article screening we excluded 380 citations. Fifty-five studies, reported in 59 articles, were included.

Figure 2Summary of search (number of articles)

CHD = coronary heart disease; LDL = low-density lipoprotein; RCT = randomized controlled trial; SIP = Scientific Information Packet

a Total exceeds the number of citations in the exclusion box because citations could be excluded for more than one reason.

b Sharma M, Ansari MT, Soares-Weiser K, Abou-setta AM, Ooi TC, Sears M, Yazdi F, Tsertsvadze A, Moher D. Comparative Effectiveness of Lipid-Modifying Agents. Comparative Effectiveness Review No. 16. Rockville, MD: Agency for Healthcare Research and Quality; Sep, 2009. Prepared by the University of Ottawa Evidence-based Practice Center under Contract No. 290-02-0021. www.effectivehealthcare.ahrq.gov/reports/final.cfm.

From: Results

Cover of Combination Therapy Versus Intensification of Statin Monotherapy: An Update
Combination Therapy Versus Intensification of Statin Monotherapy: An Update [Internet].
Comparative Effectiveness Reviews, No. 132.
Monroe AK, Gudzune KA, Sharma R, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.